Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Creative Medical Technology Holdings (CELZ) EPS (Basic) (2016 - 2025)

Creative Medical Technology Holdings has reported EPS (Basic) over the past 16 years, most recently at -$0.37 for Q4 2025.

  • Quarterly EPS (Basic) rose 60.89% to -$0.37 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.95 through Dec 2025, up 44.53% year-over-year, with the annual reading at -$1.04 for FY2025, 50.0% up from the prior year.
  • EPS (Basic) was -$0.37 for Q4 2025 at Creative Medical Technology Holdings, up from -$0.48 in the prior quarter.
  • Over five years, EPS (Basic) peaked at $12.22 in Q1 2021 and troughed at -$2.61 in Q4 2021.
  • The 5-year median for EPS (Basic) is -$0.63 (2025), against an average of -$0.1.
  • The largest YoY upside for EPS (Basic) was 13477.78% in 2021 against a maximum downside of 12400.0% in 2021.
  • A 5-year view of EPS (Basic) shows it stood at -$2.61 in 2021, then soared by 79.69% to -$0.53 in 2022, then plummeted by 125.0% to -$1.19 in 2023, then increased by 21.62% to -$0.93 in 2024, then skyrocketed by 60.89% to -$0.37 in 2025.
  • Per Business Quant, the three most recent readings for CELZ's EPS (Basic) are -$0.37 (Q4 2025), -$0.48 (Q3 2025), and -$0.48 (Q2 2025).